Aktie 301093 JIANGSU HUALAN NEW PHARMACEUTICAL MATERIAL CO.,LTD.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Jiangsu Hualan New Pharmaceutical Material Co.,Ltd.

Aktien

301093

CNE100004YH2

301093

Schlusskurs Shenzhen S.E.
Andere Börsenplätze
 00:00:00 15.05.2024 		% 5 Tage % 1. Jan.
22,48 CNY -1,19 % Intraday Chart für Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. -3,35 % -30,40 %
25.04. Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. meldet Ergebnis für das erste Quartal zum 31. März 2024 CI
21.04. Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
Tranche Update on Jiangsu Hualan New Pharmaceutical Material Co.,Ltd.'s Equity Buyback Plan announced on June 6, 2023.
Jiangsu Hualan New Pharmaceutical Material Co.,Ltd.'s Equity Buyback announced on June 6, 2023 has closed with 6,412,625 shares, representing 4.81% for CNY 199.59 million.
Tranche Update on Jiangsu Hualan New Pharmaceutical Material Co.,Ltd.'s Equity Buyback Plan announced on June 6, 2023.
Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
Tranche Update on Jiangsu Hualan New Pharmaceutical Material Co.,Ltd.'s Equity Buyback Plan announced on June 6, 2023.
Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. Announces Final Dividend on A Shares for the Year 2022, Payable on July 6, 2023
Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. commences an Equity Buyback Plan for CNY 200 million worth of its shares, under the authorization approved on May 26, 2023.
Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. Approves Cash Dividend for the Year 2022
Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. Proposes Final Cash Dividend for 2022
Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
Jiangsu Hualan New Pharmaceutical Material Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
Jiangsu Hualan New Pharmaceutical Material Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
Chongqing Fuling Sanhai Lanling Co., Ltd. announced that it expects to receive CNY 576.3965 million in funding from Jiangsu Hualan New Pharmaceutical Material Co.,Ltd.
Jiangsu Hualan New Pharmaceutical Material Co., Ltd. Announces 2021 Final Profit Distribution Plan to Be Implemented (A Shares), Payment Date: 07 June 2022
Jiangsu Hualan New Pharmaceutical Material Co., Ltd. Approves Cash Dividend for 2021
Jiangsu Hualan New Pharma to List 1.8 Million Shares Post IPO Lock-Up Period
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. 301093 Aktie
  4. Nachrichten Jiangsu Hualan New Pharmaceutical Material Co.,Ltd.
  5. Andere Sprachen